Hem › Major depression › Missouri
Kliniska studier för Major depression i Missouri
16 studier för Major depression söker deltagare vid platser i Missouri.
Städer i Missouri
Officiell studietext (engelska)
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Psychiatric Care and Research Center (PCRC), O'Fallon
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Saint Charles
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06830044Lumateperone for Late-Life Depression
- Washington University School of Medicine, St Louis
RekryterarFas 3
Ålder 60 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07623135A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, St Louis
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- St. Charles Psychiatric Associates, Inc. dba Midwest Research Group, Saint Charles
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Psychiatric Care and Research Center, O'Fallon
- St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Washington University School of Medicine, St Louis
Rekryterar
Ålder 22 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Arch Clinical Trials, LLC, St Louis
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Arch Clinical Trials, St Louis
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Tekton Research, St Louis
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
- Neurocrine Clinical Site, Saint Charles
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Midwest Research Group, Saint Charles
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 11 maj 2026 · NCT06524830NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
- Washington University School of Medicine, St Louis
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 29 apr. 2026 · NCT02994433Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #127, Saint Charles
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 20 jan. 2026 · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Saint Charles
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 23 jan. 2025 · NCT06223880Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.